RELATIONSHIP CHARACTERISTICS OF COVID-19 PATIENTS WITH SGOT AND SGPT LEVELS

Salbiah Salbiah, Liza Liza, Indarsita Dina, Ariska Sri

Abstract




Laboratory tests on COVID-19 patients include hematology, clinical chemistry, and molecular
examinations. According to several studies, patients infected with COVID-19 have impaired liver
function which is characterized by an increase in SGOT and SGPT. An increase in liver enzymes is
also a sign of liver injury.The purpose of this study was to determine  the relationship between the
characteristics of COVID-19 patients with SGOT and SGPT  levels.  The research method is
analytic observational with cross sectional design. . This research was conducted at Adhyaksa
General Hospital in Jakarta. The sample of this study is medical record data of COVID-19 patients
with positive PCR results who carried out SGOT and SGPT examinations for the period January -
April 2021 on 90 patiens.The results showed that as many as 76.7% of patients experienced an
increase in SGOT levels and 77.8% of patients on SGPT, with age 50 years as many as 57.8% and
male sex as much as 66.7%, the general condition of patients in medium level as much as 72.2%.The
results of statistical tests using the chi square test showed that there was no significant relationship
between the characteristics of COVID-19 patients and levels of SGOT and SGPT. This is because
there are other mechanisms that affect the enzymatic state of the liver, especially SGOT and SGPT.


Full Text:

PDF

References


Agarwal, A., Chen, A., Ravindran, N.,

To, C., & Thuluvath, P. J. (2020).

Gastrointestinal and Liver

Manifestations of COVID-19.

Journal of Clinical and

Experimental Hepatology,10(3),

–265.

https://doi.org/10.1016/j.jceh.2020.0

001

Agustina, A. S., & Fajrunni’mah, R.

(2020). Perbandingan Metode RT-PCR

dan Tes Rapid Antibodi untuk

Deteksi COVID-19. Jurnal

Kesehatan Manarang, 6, 47.

https://doi.org/10.33490/jkm.v6ikhu

sus.317

Andreas, M., Romansyah, M. A., &

Zuandra, R. A. (2020). Laporan

Kasus Silent Hypoxemia pada

Penderita COVID-19 dengan

Komorbid Diabetes Melitus. Medica

Hospitalia : Journal of Clinical

Medicine.

https://doi.org/10.36408/mhjcm.v7i

a.478

Chen, N. C., Zhou, M., Dong, X., Qu, J.,

Gong, F., Han, Y., Qiu, Y., Wang,

J., Liu, Y., Wei, Y., Xia, J., Yu, T.,

Zhang, X., & Zhang, L. (2020).

Garrido, I., Liberal, R., & Macedo, G.

(2020). Review article : COVID-19

and liver disease — what we know

on. April, 1–9.

https://doi.org/10.1111/apt.15813

Haitao, T., Vermunt, J. V., Abeykoon, J.,

& Ghamrawi, R. (2020). COVID-19

and Sex Differences: Mechanisms

and Biomarkers. January.

Handayani, D., Hadi, D. R., Isbaniah, F.,

Burhan, E., & Agustin, H. (2020).

Penyakit Virus Corona 2019. Jurnal

Respirologi Indonesia.

Hardani, M. (2018). Hubungan Hasil

Pemeriksaan Aspartate

Transaminase dan Alanine

Transaminase Terhadap Derajat

Keparahan Pasien Infeksi Dengue

di RS Urip Sumoharjo

Bandarlampung.

http://digilib.unila.ac.id/30217/3/SK

RIPSI TANPA BAB

PEMBAHASAN.pdf

Hwaiz, R., Merza, M., Hamad, B., &

Hamasalih, S. (2020). Evaluation of

Hepatic Enzymes Activities in

COVID-19 Patients. January.

Kang, Y., & Xu, S. (2020).

Comprehensive Overview of

COVID-19 Based on CurrentEvidence. April, 1–8.

https://doi.org/10.1111/dth.13525

Kangdra, W. Y. (2021). Karakteristik

Klinis dan Faktor Komorbid pada

Pasien dalam Pengawasan (PDP)

Coronavirus Disease 2019 (COVID19)

di

RS

Mitra

Medika

Amplas.

Kementerian Kesehatan RI, 2021. (2021a).

Surat Edaran Nomor : HK.02.02/II/

/2021 tentang Percepatan

Pelaksanaan Vaksinasi COVID-19

pada Kelompok Pra Lansia dan

Hasil BPOM terkait Vaksin

COVID-19 Astrazeneca.

Kementerian Kesehatan RI, 2021,

https://www.kemkes.go.id/article/vi

ew/19093000001/penyakit-jantungpenyebab-kematian-

terbanyak-ke2-di-indonesia.html

Kementerian Kesehatan RI, 2021.

(2021b). Tata Laksana. Protokol

Tata Laksana COVID-19, 2.

https://kbbi.kemdikbud.go.id/entri/T

ata Laksana

Keputusan Menteri Kesehatan Republik

Indonesia Nomor

HK.01.07/MENKES/413/2020

tentang Pedoman Pencegahan dan

Pengendalian Coronavirus Disease

(COVID-19). (2020).

KEPUTUSAN MENTERI

KESEHATAN REPUBLIK

INDONESIA NOMOR

HK.01.07/MENKES/413/2020

TENTANG PEDOMAN

PENCEGAHAN DAN

PENGENDALIAN CORONAVIRUS

DISEASE 2019 (COVID-19) (Vol.

.

Khairina Putri Faisal, H., Khairan, P.,

Mutmainah, I., Nur Rahmawati, F.,

Shafa Marwadhani, S., Novitri

Adinda, G., Nilam Sari, U.,

Prawirohardjo, P., Muhammadiyah

Jakarta, U., Umum, D., Ptt, D.,

Marsidi Judono, R. H., Belitung, B.,

& Kasus, L. (2020). Kasus COVID19

Ringan Pada Tenaga Medis:

Evaluasi Temuan Klinis dan Risiko

Transmisi. Journal Of The

Indonesian Medical Association.

Kumar, A., Kumar, P., Dungdung, A.,

Gupta, A. K., & Anurag, A. (2020).

Pattern of Liver Function and

Clinical Profile in COVID-19 : A

Crosssectional Study of 91 Patients.

January.

A

L

O

K

E

S

S

T

H

Y

N

I

G

G

I

I

L

M

E

D

Z

N

A

S

A

I

U

K

E

S

E

H

T

I

K

A

T

A

N

A

Lia, A., Irwan, & Hiola, F. (2020).

Kekebalan Tubuh untuk Mencegah

Penyakit COVID-19Analysis of

Clinical Symptoms and Immune

Enhancement to Prevent COVID-19

Disease.JAMBURA JURNAL of

Health Sciences and Research.

Pariang, N. F. ., Wijaya, E., Sarnianto,

P., Ikawati, Z., Andrajati, R.,

Puspitasari, I., & Noviani, L.

(2020). Panduan Praktis Untuk

Apoteker Menghadapi Pandemi

COVID-19. Pengurus Pusat Ikatan

Apoteker Indonesia, 53(9), 1779–

Partakusuma, L. G., Kita, R. J. & P. D.

H., Pusat, P. P., & PUSAT, PERSI,

G. T. P. P. C.-19 (Lab). (2020).

Manajemen laboratorium rumah

sakit sebagai upaya memperpendek

masa rawat pasien covid-19. 19.

Peta Sebaran COVID-19. (2021).

https://covid19.go.id/peta-sebarancovid19

Sridanti, R. (2019). Gambaran Aktivitas

Enzim SGOT dan SGPT pada

Pasien Hepatitis di RSUD

Bangkinang.

Sukmana, M., & Yuniarti, F. A. (2020).

The Pathogenesis Characteristics

and Symptom of Covid-19 in the

Context of Establishing a Nursing

Diagnosis. Jurnal Kesehatan Pasak

Bumi Kalimantan, 3(1). Suni, N. S.

P. (2020). Kesiapsiagaan Indonesia

Menghadapi Potensi Penyebaran

Corona. Pusat Penelitian Badan

Keahlian DPR RI.

Tian, S., Hu, N., Lou, J., Chen, K.,

Kang, X., Xiang, Z., & Chen, H.

(2020). Characteristics of COVID19

Infection

in

Beijing.

January.

Wang, Y., Liu, S., Liu, H., Zhao, S.,

Zhao, J. L., & Jingmin. (2020).

SARS-CoV-2 Infection of the Liver

Directly Contributes to Hepatic

Impairment in Patiens with COVID19.

January.

World Health Organization. (2020).

Anjuran mengenai penggunaan

masker dalam konteks COVID-19.

World Health Organization.

Wu, Z., & Yang, D. (2020). A Meta ‑

Analysis of the Impact of COVID ‑

on Liver Dysfunction. European

Journal of Medical Research, 1–9.

https://doi.org/10.1186/s40001-

-00454-x Ya’qoub, L., Elgendy, I. Y., & Pepine,

C. j. (2020). Sex and Gender

Differences in COVID-19. January.

Yuliana. (2020). Corona Virus Disease

(Covid-19); Sebuah Tinjauan

Literaur. Wellnes and Healthy

Magazine.

Yusra, Y., & Pangestu, N. (2020).

Pemeriksaan Laboratorium pada

Coronavirus Disease 2019

(COVID-19). Medica

Hospitalia : Journal of

Clinical Medicine.

https://doi.org/10.36408/mhjcm.v7i

a.472


Refbacks

  • There are currently no refbacks.




Publish by Stikes Syedza Saintika Padang (Jl. Prof. Dr. Hamka No. 228 Air Tawar Timur Padang)

Contact Person :

Ns. Honesty Diana Morika, M.Kep
Editor In Chief
Pusat Penelitian dan Pengabdian Masyarakat 
STIKes SYEDZA Saintika Padang

Jl. Prof. Dr. Hamka No. 228 Air Tawar Timur Padang - Sumatera Barat